The North America Peripheral Vascular Stents Market would witness market growth of 6.2% CAGR during the forecast period (2023-2030). In the year 2019, the North America market's volume surged to 797.4 thousand units, showcasing a growth of 5.8% (2019-2022).
The market is anticipated to expand due to several factors, such as the increasing prevalence of peripheral diseases, the aging population, and the introduction of innovative products. Peripheral vascular stents are in high demand because of the rising incidence of diseases such as peripheral artery disease (PAD), atherosclerosis, and deep vein thrombosis.
Stent performance and patient outcomes have improved due to the ongoing evolution of stent design. Manufacturers have prioritized the development of stents with enhanced flexibility, deliverability, and radial strength, allowing for improved deployment and expansion within peripheral arteries. These developments have raised procedural success rates and decreased stent placement-related complications.
The stent is a self-expanding device designed for peripheral radial procedures. Introducing specialized and innovative products, such as the Smart Radianz Vascular Stent System, enables businesses to effectively meet the specific requirements of physicians and patients, enhancing their market position and competitiveness. Moreover, strategic collaborations and partnerships allow market participants to access untapped markets, thereby driving overall growth.
Healthcare initiatives and awareness campaigns in Canada aim to educate the public about the risks of PAD and the importance of early diagnosis. This increased awareness encourages individuals to seek medical care and treatment options like peripheral vascular stents. The improved prevalence of peripheral artery disease (PAD) in Canada significantly impacts the and associated medical procedures. Therefore, the region presents lucrative growth prospects for the market.
The US market dominated the North America Peripheral Vascular Stents Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $739.1 million by 2030. The Canada market is experiencing a CAGR of 8.6% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 7.7% during (2023 - 2030).
Based on Mode of Delivery, the market is segmented into Balloon-expandable Stents, and Self-expanding Stents. Based on End-use, the market is segmented into Hospitals & Cardiac Centers, Ambulatory Surgical Centers, and Others. Based on Product, the market is segmented into Iliac Artery Stents, Femoral Artery Stents, Carotid Artery Stents, Renal Artery Stents, and Others. Based on Stents Type, the market is segmented into Drug Eluting Stents (DES), Bare Metal Stents (BMS), and Bioabsorbable Stents. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Peripheral Vascular Stents Market is Predict to reach $2.7 Billion by 2030, at a CAGR of 7.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Medtronic PLC, Terumo Corporation, Abbott Laboratories, Biotronik SE & Co. KG, Stryker Corporation, Cook Medical, Inc. (Cook Group), MicroPort Scientific Corporation, LifeTech Scientific Corporation and iVascular S.L.U.
By Mode of Delivery (Volume, Thousand Units, USD Million, 2019-2030)
By End-use (Volume, Thousand Units, USD Million, 2019-2030)
By Product (Volume, Thousand Units, USD Million, 2019-2030)
By Stents Type (Volume, Thousand Units, USD Million, 2019-2030)
By Country (Volume, Thousand Units, USD Million, 2019-2030)
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
